Poster Session 1: Clinical Cellular Therapy

Track: Poster Abstracts
Wednesday, February 11, 2015: 6:45 PM-7:45 PM
Grand Hall CD (Manchester Grand Hyatt)

170
In Vitro Expanded Umbilical Cord Blood T Cells Used for Donor Lymphocyte Infusions after Umbilical Cord Blood Transplantation
Sofia Berglund, MD, Karolinska Univers. Hospital/Karolinska Institute; Jens Gertow, PhD, Karolinska/Huddinge; Michael Uhlin, PhD, Karolinska University Hospital; Jonas Mattsson, MD PhD, Karolinska University Hospital

171
Immunological Effects of Decidual Stromal Cell Treatment in Patients with Severe Chronic Graft-Versus-Host Disease
Tom Erkers, MSc, Karolinska Institutet; Helen Kaipe, PhD, Karolinska Institutet; Silvia Nava, BSc, Karolinska Institutet; Pia Molldén, BSc, Karolinska Institutet; Britt Gustafsson, Huddinge University Hospital; Rimma Axelsson, MD, PhD, Karolinska University Hospital; Olle Ringden, MD, PhD, Karolinska Institutet

172
Increased Collection Efficiency of Spectra OPTIA Reduces the Blood Volume Processed to Acquire Targeted CD34+ Dose
Cheryl Gottsacker, Cancer Treatment Centers of America @ Midwestern Regional Medical Center; Adetola Akinwande, Cancer Treatment Centers of America @ Midwestern Regional Medical Center; Tamara Loos, PhD, Terumo BCT; Monika Payne, Cancer Treatment Centers of America @ Midwestern Regional Medical Center; Syed A. Abutalib, MD, Cancer Treatment Centers of America @ Midwestern Regional Medical Center; Bradford Tan, MD, Cancer Treatment Centers of America @ Midwestern Regional Medical Center

173
Administration of LMP-Specific Cytotoxic T-Lymphocytes to Patients with Relapsed EBV-Positive Lymphoma Post Allogeneic STEM CELL Transplant
Serena Kimi Perna, MD, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital; Stephen Gottschalk, MD, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital; Vicky Torrano, BS, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital; Oumar Diouf, BS, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital; Renuka P Miller, PhD, Children’s National Medical Center; George Carrum, MD, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital; Carlos A. Ramos, MD, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital; Hao Liu, Baylor College of Medicine; Men-Feng Wu, Baylor College of Medicine; Robert A. Krance, MD, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital; Kathryn Leung, MD, Baylor College of Medicine, Texas Children's Hospital; Adrian P. Gee, PhD, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital; Cliona M. Rooney, PhD, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital; Malcolm K. Brenner, MD, PhD, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital; Helen E. Heslop, MD, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital; Catherine M. Bollard, MD, Children's National Medical Center

174
Placenta-Derived Decidual Stromal Cells for Graft-Versus-Host Disease, Hemorrhaging, and Toxicity after Allogeneic Hematopoietic Stem Cell Transplantation
Olle Ringden, MD, PhD, Karolinska Institutet; Martin Solders, MD, Karolinska Institutet; Tom Erkers, MSc, Karolinska Institutet; Silvia Nava, BSc, Karolinska Institutet; Pia Molldén, BSc, Karolinska Institutet; Bita Khoein, Karolinska Institutet; Arjang Baygan, Karolinska Institutet; Wictor Aronsson-Kurttila, Karolinska Institutet; Salimullah Mohmand, Karolinska Institutet; Mats Remberger, PhD, Karolinska University Hospital; Magnus Westgren, MD, PhD, Karolinska Institutet; Jonas Mattsson, MD PhD, Karolinska University Hospital; Behnam Sadeghi, MD PhD, Karolinska Institutet; Helen Kaipe, PhD, Karolinska Institutet

175
Establishment of a Highly Characterized Third-Party Virus-Specific T Lymphocyte Bank for Treatment of EBV+ Lymphoma
Rayne Helen Rouce, M.D., Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital; Serena K. Perna, M.D., Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital; Gayatri Vyas, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital; Sandhya Sharma, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital; Manasa Hiregange, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital; Natalia Lapteva, PhD, Baylor College of Medicine/Center for Cell and Gene Therapy; Ann M. Leen, PhD, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital; Helen E. Heslop, MD, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital; Ifigenia Tzannou, MD, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital; Carlos Ramos, MD, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital; Cliona M. Rooney, PhD, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital

176
Treatment of Secondary Graft Failure after Hematopoietic Stem Cell Transplantation with Alpha/Beta T-Cell Depleted Grafts As Booster Infusions
Emelie Rĺdestad, Karolinska Institutet; Helena Wikell, Karolinska University Hospital; Mats Engström, MD, Karolinska University Hospital; Emma Watz, MD, Karolinska Institutet; Berit Sundberg, Karolinska University Hospital; Sarah Thunberg, PhD, Karolinska University Hospital; Mehmet Uzunel, PhD, Karolinska University Hospital; Jonas Mattsson, MD PhD, Karolinska University Hospital; Michael Uhlin, PhD, Karolinska University Hospital

178
NOVEL Strategy to Enhance NK CELL Activity
Reshmi Parameswaran, Case Western Reserve University; Basem M. William, MD, MRCP(UK), University Hospitals Seidman Cancer Center and Case Western Reserve University; Stephen Moreton, Case Western Reserve University; Dean Lee, MD, PhD, University of Texas MD Anderson Cancer Center; Paramaeswaran Ramakrishnan, Case Western Reserve University; Marcos J. G. de Lima, MD, University Hospitals Seidman Cancer Center and Case Western Reserve University; David Wald, Case Western Reserve University

179
Spinal Cord Injection of Stem Cells for Pediatric ALS
Laura L Worth, MD, PhD, University of Texas MD Anderson Cancer Center; John Mark Slopis, MD, MPH, M D Anderson Cancer Center; Mary Kay Koenig, MD, University of TX Health Science Center at Houston; Richard E. Champlin, MD, The University of Texas MD Anderson Cancer Center; Ian E McCutcheon, MD, M D Anderson Cancer Center

See more of: Poster Abstracts